Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Futures Kickoff
Get prepared for your futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
RBC Capital Initiates Coverage on AbbVie (ABBV) with Outperform Rating | ABBV Stock News
RBC Capital has initiated coverage on AbbVie (ABBV) with an ‘Outperform’ rating and a price target of $260.00. This follows various recent analyst adjustments for AbbVie, reflecting differing perspectives on its market potential, with price targets ranging from $228.00 to $299.00 among other firms. AbbVie, a pharmaceutical company, is noted for its strong presence in immunology and oncology, with recent acquisitions further bolstering its portfolio.